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Proteins are an increasingly important source of new
products for numerous industries, including human and
animal health, diagnostics, health and beauty aids,
agricultural products, and chemicals. Because of the
functional roles of proteins in living systems, proteins
represent a large fraction of all biologically active mol-
ecules and the entire spectrum of biological activities. To
exploit these properties to bring new products to these
industries, there is an increasing demand for biological
systems to discover, develop and manufacture proteins.
Currently, there are a variety of systems available to
perform discovery, development and manufacturing steps
individually. However, some of these systems are limited
with regards their abilities to discover and express genes
from a large portion of the protein ‘universe’. Others are
impractical for commercial production of many proteins
because of restrictive conditions necessary for growth and
cultivation of the biological systems or the inability of
those systems to produce proteins economically at large
commercial scale.
Dyadic International is developing a system that
allows gene discovery, gene expression, product
development and manufacturing in a single biological
host. This integrated system consists of gene discovery
and gene expression components, both of which utilize
the proprietary fungal host Chrysosporium lucknowense,
or C1. C1 has diﬀerentiating advantages making it
uniquely capable of functioning as an integrated
discovery through manufacturing system. As a eukaryote,
C1 is capable of faithfully expressing genes from virtually
any source. Unlike bacteria, it is capable of splicing
introns, interrupting sequences present in many
eukaryotic genes. It is also capable of performing
post-translational modiﬁcations characteristic of many
eukaryotic proteins, for example glycosylation, with no
evidence of the hyperglycosylation described for yeast.
This allows access to portions of the biodiverse gene pool
not accessible to other screening systems. Since greater
than 90% of the Earth’s species are eukaryotic by some
estimates [1, 2], the C1 system will be able to discover
genes and gene products that bacterial and yeast systems
will not be able to.
C1 also has a culture morphology, unique among fungi,
that confers the ability not only to grow in up to 384-well
microtitre dishes, but also for those microvolume cultures
to be robotically transferred from well to well for culture
replication [3, 4]. Finally, C1 is capable of secreting
and producing proteins under a variety of fermentation
conditions at high yields, allowing cost-eﬀective produc-
tion of a large variety of proteins.
The gene-discovery engine utilizes robots for the prep-
aration and assay of gene expression libraries in C1.
The requisite genes can be from various sources—geno-
mic or cDNA from individual organisms, DNA isolated
from environmental samples, individual gene variant
sets generated in the laboratory. These genes are cloned
into expression vectors and introduced into C1. The
unique morphology of C1, described above, leads to
the formation of individual transferable elements, or
propagules. The formation of these propagules results
in non-viscous growth in culture, allowing adequate
aeration in microtiter wells. In addition, formation
of propagules results in lack of pelleting, surface matting
and aerial sporulation. As shown in table 1, this
eliminates canula tip clogging in robotic liquid-handling
systems. The lack of aerial sporulation, in addition,
prevents well-to-well cross-contamination.
Using a Zymark (Hopkinton, MA, USA) Allegro system,
the propagules are transferred to the wells of microtitre
dishes, each well containing on average one or a
small number of cloned genes. After cultivation in the
microtitre wells, the libraries of expressed genes are
replicated, again using the Allegro robotic system. It is
the lack of tip clogging and cross-contamination that
makes the latter step possible.
The replicate, or daughter libraries, are then assayed for
proteins or activities of interest. These can be enzymes,
targets for fungicides, pharmaceutical targets or biother-
apeutics. The assays are performed using a Zymark
Staccato system, allowing both high throughput and
ﬂexibility in the assay protocol.
Once activities are found, clones expressing the activities
are ‘cherry-picked’ from a second set of daughter plates
and re-assayed to verify the activity. The genes of interest
are isolated from individual clones expressing the activ-
ity. Since the method used for screening dictates that the
gene is expressed at some level in C1, there is a high
probability of success that the gene can be overexpressed
to commercially viable levels. Numerous tools to optimize
expression, secretion and host strain optimization have
been developed [5] and continue to be developed. Using
these tools, a number of native and heterologous genes
have been overexpressed in C1 (table 2).
After a gene has been successfully overexpressed in
the laboratory setting, versatile culture conditions
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67(table 3) allow the products of genes expressed in C1 to
be readily scaled up. The broad range of temperature
and pH, the low culture viscosity, and short cycle
time oﬀer numerous options to develop processes to
produce proteins economically that might otherwise be
unstable or produced at lower yields in other production
systems.
The C1 system is the ﬁrst integrated system of its
kind, allowing gene discovery, gene expression,
process optimization and product manufacturing in a
single host organism. That these processes can all take
place in a single organism increases the likelihood of
success and concurrently reduces the cycle time between
conception and commercialization. Reduced probability
of failure and shorter development timeline will facilitate
development of numerous new industrial, pharmaceutical
and consumer products in a timely and cost-eﬀective
manner.
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Table 1. Suitability of fungi for robotic screening.
Strain Formation of propagules Phenotype
Chrysosporium lucknowense C1 þþþþþ no tip clogging
Dyadic strain 2 þþþ no tip clogging
Dyadic strain 3 þþ no tip clogging
One fungal species þþ no tip clogging, but some large pellets
Ten fungal species  to þþ tip clogging
Table 3. Fermentation parameters for C1 and other fungi.
Aspergillus Trichoderma C. lucknowense C1
pH 3.0–6.0 3.0–6.0 4.5–9.0
Temperature (
 C) 30–37 25–32 25–44
Viscosity 1500–2000 200–1000 <10
Fermentation (days) 8–9 6–7 5
Table 2. Examples of genes expressed in C1.
Gene product Gene source Level of expression
Endoglucanase 5 C1 15g/l
Glucoamylase Aspergillus 1g/l
Interleukin 6 human 10mg/l
TNF receptor analogue human 50mg/l
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